01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
The First Circuit issued a decision holding that two private equity funds involved in a case are not...
Read More >
I’ve been an ERISA attorney for over 20 years and the one opinion I’ve had for that long is that h...
Read More >
In the past 35 years, it changed on who had to take out a required minimum distribution (RMD) from a...
Read More >
There is a significant likelihood that M&A transactions in the next year may involve PPP loans. Here...
Read More >
In the era of #MeToo, the gag order (legally speaking, non-disclosures or confidentiality clauses) h...
Read More >
Arnall Golden Gregory LLP is pleased to provide you with the Compliance News Flash, which includes c...
Read More >